• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Saturday, July 19, 2025
  • Login
News Mirror
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Mirror
No Result
View All Result
Home Lifestyle Health & Fitness

DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine

News Mirror by News Mirror
September 4, 2021
in Health & Fitness, National
Share on FacebookShare on Twitter

New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in adults of its CORBEVAX™ vaccine against COVID-19 after Subject Expert Committee’s (SEC) review of Phase I and II clinical trials data.

This follows the approval given to the company on September 1 to initiate the Phase II/III Study to evaluate the safety, reactogenicity, tolerability, and immunogenicity of the vaccine in children and adolescents. The candidate vaccine is an RBD protein subunit vaccine.

RelatedPosts

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food

VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success

Welcoming the approval, Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT) and Chairman of its public sector undertaking, Biotechnology Industry Research Assistance Council (BIRAC), said “Department of Biotechnology through Mission COVID Suraksha launched under Atma Nirbhar Bharat package 3.0 being implemented by BIRAC, is committed to the development of safe and efficacious COVID-19 vaccines. We look forward to the clinical development of candidate CORBEVAX™ for paediatric and adults.”

Ms Mahima Datla, Managing Director, Biological E. Limited, said-“We are delighted to receive these significant approvals from the DCGI.  These approvals encourage our organisation to move forward and successfully produce our COVID-19 vaccine to meet the vaccination needs. We are grateful to BIRAC for their support and we are enthused that these approvals would help support our subsequent filings with WHO as well. We appreciate and acknowledge the contribution of all our collaborators for their continued support in this endeavour.’’

The Department of Biotechnology has taken several initiatives to increase investments in research & development (R&D) and the manufacture of COVID-19 Vaccines. The establishment of the Mission COVID Suraksha Program is one such endeavour for COVID-19 vaccine development to reinforce and streamline available resources towards accelerated vaccine development, leading to bringing in a safe, efficacious, affordable, and accessible COVID-19 Vaccine for the citizens at the earliest with a target of Atmanirbhar Bharat.

The Department of Biotechnology and Biotechnology Industry Research Assistance Council have supported Biological E.’s COVID-19 Vaccine candidate from the preclinical stage. In addition to receiving financial assistance under Mission COVID Suraksha, this vaccine candidate has also obtained financial support under COVID-19 Research Consortia through the National Biopharma Mission of BIRAC. (India Science Wire)

Tags: accessibleaffordableAtmanirbhar BharatBiotechnology Industry Research Assistance CouncilBIRACClinical TrialCOVID-19DCGIDepartment of BiotechnologyDrugs Controller General of IndiaefficaciousimmunogenicityMission COVID SurakshaNational Biopharma MissionR&DRBD proteinreactogenicitysafetytolerabilityvaccineWHO
Previous Post

Sakhiya Skin Clinic launched Sakhiya Skin Academy in Surat

Next Post

Airgunkart – a one-stop-shop for a wide range of air guns and archery products and equipment

Related Posts

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food
Health & Fitness

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food

July 18, 2025
VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success
Health & Fitness

VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success

July 7, 2025
ClinicSpots Simplifies Online Doctor Consultation in India, Connecting Patients to Trusted Healthcare Experts Across Specialties
Health & Fitness

ClinicSpots Simplifies Online Doctor Consultation in India, Connecting Patients to Trusted Healthcare Experts Across Specialties

July 1, 2025
Revolutionizing Orthodontics with India’s First CAD/CAM-Based Lingual Bracket System
Health & Fitness

Revolutionizing Orthodontics with India’s First CAD/CAM-Based Lingual Bracket System

June 28, 2025
Giloy for the Monsoon: PravekKalp Offers a Natural Shield Against Infections
Health & Fitness

Giloy for the Monsoon: PravekKalp Offers a Natural Shield Against Infections

June 19, 2025
Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions
Health & Fitness

Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions

May 14, 2025
Next Post

Airgunkart - a one-stop-shop for a wide range of air guns and archery products and equipment

“Anil Singh Panoo and his dedicated creativity creating sensational laughs & motivation around”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

Mohobbat Ka Fitoor song by Shiraz Ahmed is all about recounting the fresh feelings of first love

August 20, 2021
Philoquent.ai: The app that helped its founder score 99.9+ percentile in the VARC section of the CAT exam

Philoquent.ai: The app that helped its founder score 99.9+ percentile in the VARC section of the CAT exam

May 5, 2023

Trending.

DHN Unveils Landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI Emerges as Top Priority

DHN Unveils Landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI Emerges as Top Priority

June 20, 2025
Raj Mishra Launches DigitechHorizons.com to Redefine Digital IP Protection for Creators and Innovators

Raj Mishra Launches DigitechHorizons.com to Redefine Digital IP Protection for Creators and Innovators

July 2, 2025
Global Innovator Radhakrishnan Arikrishna Perumal Sets a New Benchmark in Ethical AI and Insurance Technology

Global Innovator Radhakrishnan Arikrishna Perumal Sets a New Benchmark in Ethical AI and Insurance Technology

June 27, 2025
Shaligram Infotech Celebrates 10 Years of Driving Digital Innovation for Global Businesses

Shaligram Infotech Celebrates 10 Years of Driving Digital Innovation for Global Businesses

July 12, 2025
Global Health Awards 2025 Honours Excellence at the House of Lords

Global Health Awards 2025 Honours Excellence at the House of Lords

July 14, 2025
News Mirror

© 2022 News Mirror

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Follow Us

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Mirror

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In